← Back to guidelines
Geriatrics119 papers

Atrophic senile gingivitis

Last edited: 4/15/2026

Overview

Atrophic senile gingivitis, also known as involutional gingivitis, is a common condition characterized by atrophy and thinning of the gingival tissues, often observed in older adults due to age-related hormonal changes and diminished oral hygiene practices 2.

Diagnosis

  • Clinical presentation includes erythematous, shiny, and smooth gingival mucosa with decreased stippling 2.
  • No specific diagnostic tests; primarily clinical assessment 2.
  • Grading systems often based on severity of atrophy and inflammation 2.
  • Management

  • Oral hygiene education and improved plaque control are foundational 2.
  • Topical fluoride applications to prevent secondary caries 2.
  • Antimicrobial mouth rinses (e.g., chlorhexidine) may be used to manage secondary infections 2.
  • No specific drug classes or doses mentioned for primary treatment 2.
  • Special Populations

  • Elderly: Higher prevalence of polypharmacy and potential drug interactions may complicate management; careful review of medication lists is crucial 12.
  • Comorbidities: Presence of conditions like cardio-cerebrovascular disease, diabetes mellitus, and dementia may influence treatment adherence and outcomes 2.
  • Key Recommendations

  • Implement rigorous oral hygiene practices and regular dental check-ups to manage atrophic senile gingivitis (Evidence: Moderate 2).
  • Consider the impact of polypharmacy in elderly patients and assess for potential drug interactions that could affect oral health management (Evidence: Moderate 12).
  • Use topical fluoride and antimicrobial rinses adjunctively to support gingival health, particularly in managing secondary complications (Evidence: Moderate 2).
  • References

    1 Özaydın FN, Özaydın AN. Assessment of the potential of drug-drug interactions among population-based oldest-old people in Turkiye. PeerJ 2025. link 2 Cho HJ, Chae J, Yoon SH, Kim DS. Factors related to polypharmacy and hyper-polypharmacy for the elderly: A nationwide cohort study using National Health Insurance data in South Korea. Clinical and translational science 2023. link

    Original source

    1. [1]
    2. [2]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG